+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Editing Technologies Market - Global Forecast 2026-2032- Product Image
Gene Editing Technologies Market - Global Forecast 2026-2032- Product Image
New

Gene Editing Technologies Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924703
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The gene editing technologies market is undergoing significant transformation, driven by sophisticated advancements in delivery systems, diversification of core platforms, and stronger integration between scientific research and industrial applications. Senior decision-makers need a clear understanding of how changing regulations and evolving supply chains influence the practical and commercial potential of these technologies.

Market Snapshot: Gene Editing Technologies

The Gene Editing Technologies Market expanded from USD 20.59 billion in 2025 to USD 23.17 billion in 2026, with a projected CAGR of 14.78%. By 2032, the sector is expected to reach USD 54.08 billion. This rapid trajectory is fueled by increased adoption across medical, agricultural, and industrial sectors, with early movers gaining competitive advantage through strategic alignment and robust R&D investments.

Scope & Segmentation

  • Technology Platforms: CRISPR (including innovations like base and prime editing, as well as Cas9 variants), meganucleases, TALENs, and zinc finger nucleases each serve tailored scientific and business objectives.
  • Application Focus Areas: Market solutions target human therapeutics such as oncology and rare diseases, agricultural bioengineering for crop and livestock improvements, industrial biosynthesis, and research tools like assay development and cell engineering.
  • Delivery Methods: Nonviral techniques, including electroporation, lipid nanoparticles, and microinjection, as well as viral vector solutions using adeno-associated viruses, lentiviruses, and retroviruses enable precise editing applications.
  • End-User Segments: Major stakeholders are large and mid-sized biopharmaceutical companies, contract research and manufacturing organizations, medical centers, hospitals, academic research institutes, and government laboratories.
  • Disease Areas: Targeted indications include hematologic malignancies, solid tumors, cystic fibrosis, sickle cell disease, and inherited genetic disorders that demand precision and customization in editing strategies.
  • Regions Covered: The market encompasses the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaped by unique infrastructure assets, regulatory environments, and sector maturity.

Key Takeaways for Decision-Makers

  • Platform diversification introduces enhanced specificity and expands the range of possible applications for both clinical and industrial stakeholders, making risk management in validation more important.
  • Efficient delivery tools offer improved performance for ex vivo manipulations as well as in vivo therapeutic interventions, supporting broader accessibility across disease types and industries.
  • As regulatory demands increase, proactive engagement and early dialogue with governing bodies are essential for securing approvals and minimizing compliance risks.
  • Collaborative projects among biotechnology firms, academic groups, and contract partners accelerate project timelines and distribute R&D risks across the ecosystem.
  • Clear segmentation of technology, delivery pathway, and user needs helps bridge the gap between technical capability and evolving demand, strengthening strategic planning.

Tariff Impact on Procurement and Supply Chain Stability

With the imposition of tariffs and trade measures from 2025, procurement cycles for specialized reagents and gene editing components have experienced delays and cost increases. Many organizations are now reassessing their supplier networks, emphasizing additional vendor qualification, adopting redundant sourcing, and considering local manufacturing to reduce dependency risks. These adaptive strategies influence decisions between outsourcing and in-house production. Contract research and manufacturing organizations with geographic flexibility and high reliability are emerging as preferred partners in the shifting supply landscape.

Gene Editing Technologies Market – Methodology & Data Sources

Research findings within this Gene Editing Technologies Market report are derived from structured interviews with domain experts across biotechnology, clinical, and contract manufacturing domains. Supplementary evidence includes peer-reviewed scientific publications, regulatory documents, and public company filings. Analytical methods covered trend validation, supplier performance benchmarking, and evaluation of regulatory timelines, ensuring data is cross-checked and conservatively interpreted for actionable insights.

Why This Report Matters

  • Offers senior leadership a reliable benchmark on technology trends, market developments, and competitor positioning, informing portfolio and operational strategy.
  • Identifies procurement and supply chain vulnerabilities, providing greater transparency into lead times and regulatory shifts across global regions.
  • Supports investment and partnership decision-making with focused segmentation and practical recommendations for sustainable growth.

Conclusion

This report helps executives align scientific progress with operational agility and strategic foresight. Adapting rapidly to regulatory and technological changes is essential to secure advantages as the gene editing sector advances.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Gene Editing Technologies Market, by Technology Platform
8.1. CRISPR
8.1.1. Base Editing
8.1.1.1. Adenine Base Editing
8.1.1.2. Cytosine Base Editing
8.1.2. Cas9
8.1.3. Prime Editing
8.2. Meganuclease
8.3. TALEN
8.4. ZFN
9. Gene Editing Technologies Market, by Delivery Method
9.1. Nonviral
9.1.1. Electroporation
9.1.2. Lipid Nanoparticle
9.1.3. Microinjection
9.2. Viral
9.2.1. Adeno Associated Virus
9.2.2. Lentivirus
9.2.3. Retrovirus
10. Gene Editing Technologies Market, by Disease Indication
10.1. Infectious Diseases
10.2. Oncology
10.2.1. Hematological Malignancies
10.2.2. Solid Tumors
10.3. Rare Genetic Disorders
10.3.1. Cystic Fibrosis
10.3.2. Sickle Cell Disease
11. Gene Editing Technologies Market, by Application
11.1. Agricultural
11.1.1. Crops
11.1.2. Livestock
11.2. Industrial
11.2.1. Biofuels
11.2.2. Bioplastics
11.3. Research Tools
11.3.1. Assays
11.3.2. Cell Line Engineering
11.3.3. Library Screening
11.4. Therapeutic
11.4.1. Ex Vivo
11.4.1.1. Immunotherapy
11.4.1.2. Stem Cell Therapy
11.4.2. In Vivo
11.4.2.1. Germline Gene Editing
11.4.2.2. Somatic Gene Editing
12. Gene Editing Technologies Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Gene Editing Technologies Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Gene Editing Technologies Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Gene Editing Technologies Market
16. China Gene Editing Technologies Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Agilent Technologies, Inc.
17.6. AMS Biotechnology Ltd.
17.7. Beam Therapeutics Inc.
17.8. Caribou Biosciences, Inc.
17.9. Cellectis SA
17.10. Creative Biogene
17.11. CRISPR Therapeutics AG
17.12. Editas Medicine, Inc.
17.13. GenScript Biotech Corporation
17.14. Horizon Discovery Ltd.
17.15. Inscripta, Inc.
17.16. Integrated DNA Technologies, Inc.
17.17. Intellia Therapeutics, Inc.
17.18. Lonza Group Ltd.
17.19. Mammoth Biosciences, Inc.
17.20. Merck Group
17.21. New England Biolabs, Inc.
17.22. OriGene Technologies, Inc.
17.23. Precision BioSciences, Inc.
17.24. Sangamo Therapeutics, Inc.
17.25. Synthego Corporation
17.26. Takara Bio Inc.
17.27. Tecan Trading AG
17.28. Thermo Fisher Scientific, Inc.
List of Figures
FIGURE 1. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENINE BASE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENINE BASE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENINE BASE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYTOSINE BASE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYTOSINE BASE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYTOSINE BASE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CAS9, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CAS9, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CAS9, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRIME EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRIME EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRIME EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEGANUCLEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEGANUCLEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEGANUCLEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZFN, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZFN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZFN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIPID NANOPARTICLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIPID NANOPARTICLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIPID NANOPARTICLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LENTIVIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LENTIVIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RETROVIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RETROVIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RETROVIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYSTIC FIBROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SICKLE CELL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SICKLE CELL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CROPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CROPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CROPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIBRARY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIBRARY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIBRARY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY STEM CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY STEM CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GERMLINE GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GERMLINE GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GERMLINE GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOMATIC GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOMATIC GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOMATIC GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 210. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 212. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 213. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 214. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 215. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 216. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 217. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 218. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 219. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 220. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 222. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 223. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 224. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 225. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 226. EUROPE GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 239. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 240. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 241. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 242. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 243. MIDDLE EAST GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 244. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 245. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 246. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 247. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 248. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 249. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 250. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 251. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 252. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 253. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 254. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 256. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 257. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 258. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 259. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 260. AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 269. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 270. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 271. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 273. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 274. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 275. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 276. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 277. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 278. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 279. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 281. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 282. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 283. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 284. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 285. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 286. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 287. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 288. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 289. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 290. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 291. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 292. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 293. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 294. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 295. ASEAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 296. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 297. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 298. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 299. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 300. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 301. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 302. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 303. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 304. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 305. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 306. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 308. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
TABLE 309. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2032 (USD MILLION)
TABLE 310. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 311. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 312. GCC GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 315.

Companies Mentioned

The key companies profiled in this Gene Editing Technologies market report include:
  • Agilent Technologies, Inc.
  • AMS Biotechnology Ltd.
  • Beam Therapeutics Inc.
  • Caribou Biosciences, Inc.
  • Cellectis SA
  • Creative Biogene
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Ltd.
  • Inscripta, Inc.
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Mammoth Biosciences, Inc.
  • Merck Group
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Precision BioSciences, Inc.
  • Sangamo Therapeutics, Inc.
  • Synthego Corporation
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 23.17 Billion
Forecasted Market Value ( USD ) by 2032 $ 54.08 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Genome Editing Market - Global Forecast 2026-2032 - Product Image

Genome Editing Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Genome Editing Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Genome Editing Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Genome Editing Market Report by Technology, Delivery Method, Application, Mode, End-Use, Countries and Company Analysis, 2025-2033 - Product Image

Genome Editing Market Report by Technology, Delivery Method, Application, Mode, End-Use, Countries and Company Analysis, 2025-2033

  • Report
  • 200 Pages
  • Global
From
Meganuclease Genome Editing Market Report 2025 - Product Image

Meganuclease Genome Editing Market Report 2025

  • Report
  • 250 Pages
  • Global
From
CRISPR Gene Editing Market - Global Forecast 2026-2032 - Product Image

CRISPR Gene Editing Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.